- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04104516
Lifestyle Modification Program for Lung Cancer Patients - Physical Activity Preference
A Brief Messaging Lifestyle Modification Program for Patients With Non-small Cell Lung Cancer
Studieoversikt
Status
Forhold
Detaljert beskrivelse
Lung cancer is one of the most common cancer globally and locally. Patients with lung cancer are in a uniquely difficult situation in their disease, comorbidities, and treatment that may lead to worsened symptoms and many negative health consequences, including fatigue, irritability, and impaired daytime functioning.
Physical activity (PA) is defined as 'any bodily movement produced by skeletal muscle that results in energy expenditure'. Several health benefits of increased PA have been reported for people with cancer. PA plays a critical role across the cancer trajectory, from prevention through to post-diagnosis and has been proposed as an alternative for improving physical and psychosocial health outcomes, reducing cancer recurrence, and cancer-specific and all-cause mortality. However, most of the findings were predominantly in breast and colorectal cancers. The PA dosage required to attain health benefits across these cancer groups is not uniform, nor is it clear whether the results can be applied to other groups of people with cancer.
The current study includes a cross-sectional questionnaire survey and an in-depth interview. It aims to understand the current physical activity practice and preference of patients with lung cancer, which could help to develop a lifestyle modification program based on our patients' needs and preferences.
Studietype
Registrering (Forventet)
Kontakter og plasseringer
Studiesteder
-
-
-
Hong Kong, Hong Kong
- Rekruttering
- Queen Mary Hospital
-
Ta kontakt med:
- Agnes YK Lai, PhD
- Telefonnummer: 852-3917-6328
- E-post: agneslai@hku.hk
-
Ta kontakt med:
- Mary MS Ip, MD
- Telefonnummer: 852-2255-4455
- E-post: msmip@hku.hk
-
Hovedetterforsker:
- Agnes y Lai, PhD
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Aged 18 years and above;
- Diagnosis with non-small cell lung cancer
- General condition stable, either is undergoing or finished treatment
- Able to speak and read Chinese
- Able to complete the self-administered questionnaire
- Mental, cognitive and physically fit for joining the trial as determined by the clinician or responsible investigator
Exclusion Criteria:
- Mentally unfit for answering questionnaire
- Unable to give informed consent
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Preference on physical activity program
Tidsramme: immediately after obtaining written consent
|
Outcome-based questions with categorical choices
|
immediately after obtaining written consent
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Current physical activity practise
Tidsramme: immediately after obtaining written consent
|
Outcome-based questions with categorical choices
|
immediately after obtaining written consent
|
|
Preference on information to be received
Tidsramme: immediately after obtaining written consent
|
Outcome-based questions with categorical choices
|
immediately after obtaining written consent
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: LAI YK Agnes, PhD, School of Nursing, The University of Hong Kong
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep. 1985 Mar-Apr;100(2):126-31.
- Peddle-McIntyre CJ, Singh F, Thomas R, Newton RU, Galvao DA, Cavalheri V. Exercise training for advanced lung cancer. Cochrane Database Syst Rev. 2019 Feb 11;2(2):CD012685. doi: 10.1002/14651858.CD012685.pub2.
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- UW19-597-1
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .